Twist Bioscience Operating Income

Twist Bioscience (TWST) currently reports a operating income of $-140M as of June 2026. That compares with $-140M in the prior-year period — down 1.8% year over year. Use the charts on this page to explore Twist Bioscience's operating income history and peer comparisons.

Twist Bioscience's operating income decreased from $-140M to $-140M — a 1.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Twist Bioscience reported $-140M in operating income as of June 2026. That compares with $-140M in the prior-year period — down 1.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Twist Bioscience, and consider following TWST for alerts when major investors trade the stock.

Twist Bioscience is classified in the Healthcare sector. On operating income, it currently shows $-140M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TWST with unrelated industries.